Spinnovation Biologics

Spinnovation Biologics

NEWS RELEASE | Nijmegen, 7 April 2011 (in English)

Spinnovation launch new biologics division with unique service provision

 7 April 2011: Spinnovation, Nijmegen, The Netherlands: On 7 April 2011, Frederic Girard, CEO of integrated NMR specialists, Spinnovation Analytical BV (Nijmegen, The Netherlands), announced the launch of a new division of the company – Spinnovation Biologics – at the annual meeting of the Flanders Biotech group.

Extending the company’s current contract research and contract analysis services, the new division will provide a unique mix of services for spent culture media analysis, and the profiling and characterization of biologics and biosimilars.

Dr Girard said, “With this exciting launch of the Biologics division we aim to further our commitment to bringing rapid solutions for the problems faced by our clients. The new core service; spent media analysis with Spedia-NMR™, is unique and can deliver a step-fold increase in throughput and detail over standard methods, in as few as five working days. We know that our cost-effective package, delivered through flexible service agreements, is exactly what our pharma and biotech customers need.

In addition to spent media analysis, Spinnovation Biologics offers both process and product bioanalysis,” continued Dr Girard. “This means that our clients can also benefit from advanced insights into cell culture to enhance productivity, scalability, and reliability for QA/QC control, cGMP production and support Quality by Design.

Experts in nuclear magnetic resonance spectroscopy (NMR) methods and techniques, Spinnovation Biologics also has a broad spectrum of analysis methods in house, including: LC-MS, LC-NMR, LC-SPE-NMR and LC-SPE-NMR-MS, as well as its Spedia-NMR™ technology. For further information, please visit: www.spinnovation-biologics.com

End

 Spedia-NMR™ is a registered trademark of Spinnovation Analytical BV

 

High resolution image attached or available from Claire England,

Kapler Communications This e-mail address is being protected from spambots. You need JavaScript enabled to view it Ref: SPI/JOB/002

 

CAPTION: Spinnovation Biologics delivers rapid, cost effective bioanalysis services for spent culture media, and the profiling and characterization of biologics and biosimilars

SPI-JOB-002-Image

 

About Spinnovation Analytical BV

Spinnovation Biologics is a division of Spinnovation Analytical BV (Nijmegen, The Netherlands, www.spinnovation-analytical.com).

 

Spinnovation is a contract research organization expert in delivering analytical service to the Industry (Pharmaceuticals, Chemicals/Polymers, Food Products). Its expertise and core activity focuses on the use of Nuclear Magnetic Resonance Spectroscopy (NMR) and Mass Spectrometry (MS) to study molecules and materials.

 

For more information:

soc-med

 

links are:

http://www.linkedin.com/company/spinnovation-analytical

http://twitter.com/#!/spinnovationNL

 

For press information, please contact:

Richard Kent, Kapler Communications

Knowledge Centre, Wyboston Lakes, Great North Road,

Wyboston, Bedfordshire, MK44 3BY, UK

Tel: +44 (0)1480 479280; Fax: +44 (0)1480 470343 This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

Spinnovation contact:

Dr. Frederic Girard, Spinnovation Analytical BV, Toernooiveld 100, P.O.Box 6503CB Nijmegen, the Netherlands. tel.: +31 (0)24-240-3400, e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

Press Release in PDF format

SPI-JOB-002_Spinnovation.pdf

 

   

 
 

Spinnovation Analytical is part of Sinensis Life Sciences

visit website x